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Abstract
Background: Black elderberries (Sambucus nigra L.) are well known as supportive agents against common cold
and influenza. It is further known that bacterial super-infection during an influenza virus (IV) infection can lead to
severe pneumonia. We have analyzed a standardized elderberry extract (Rubini, BerryPharma AG) for its
antimicrobial and antiviral activity using the microtitre broth micro-dilution assay against three Gram-positive
bacteria and one Gram-negative bacteria responsible for infections of the upper respiratory tract, as well as cell
culture experiments for two different strains of influenza virus.
Methods: The antimicrobial activity of the elderberry extract was determined by bacterial growth experiments in
liquid cultures using the extract at concentrations of 5%, 10%, 15% and 20%. The inhibitory effects were
determined by plating the bacteria on agar plates. In addition, the inhibitory potential of the extract on the
propagation of human pathogenic H5N1-type influenza A virus isolated from a patient and an influenza B virus
strain was investigated using MTT and focus assays.
Results: For the first time, it was shown that a standardized elderberry liquid extract possesses antimicrobial
activity against both Gram-positive bacteria of Streptococcus pyogenes and group C and G Streptococci, and the
Gram-negative bacterium Branhamella catarrhalis in liquid cultures. The liquid extract also displays an inhibitory
effect on the propagation of human pathogenic influenza viruses.
Conclusion: Rubini elderberry liquid extract is active against human pathogenic bacteria as well as influenza
viruses. The activities shown suggest that additional and alternative approaches to combat infections might be
provided by this natural product.
Background
Elders (Sambucus spp.) are widely distributed through-
out the world. In central Europe, the most common
species are black elder (Sambucus nigra L.), red elder
(Sambucus racemosa L.), and dwarf elder (Sambucus
ebulus L.). Black elder is the most widespread, being
found across Europe, central and western Asia, and
northern Africa [1]. Black elder is a deciduous shrub
that grows to a height of 4-6 m. From spring until sum-
mer the corymbs are in flower. The berries are dark vio-
let-black drupes which grow in clusters and are only
edible when fully ripe. Other parts of the plant, such as
the green stems and branches, are not edible and not
recommended for human consumption.
In 400 BCE, Hippocrates referred to the elder tree as
his “medicine chest.” Other noted classical healers,
including Theophrastus, Dioscorides and Galen,
regarded the elder as one of nature’s greatest healing
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th
century, and the physician and author, Dr. Martin
Blochwich in the 17
th century, continued to extol its vir-
tues [2]. In the early 20
th century, British herbalist Maud
Grieves provided a comprehensive review of the histori-
cal uses of black elder as a traditional medicine [3].
Prior to antibiotics, elderberry was found as one of the
main ingredients in many preparations used by herbal-
ists [4], pharmacists, and physicians. Today, elderberry
is employed as an alternative to conventional medicines
and mainly in the form of an extract for treating the
common cold, influenza and Herpes virus infections
[5-9]. Elderberry is often recommended for use as a
complementary therapy together with the classic antiox-
idant nutrients, vitamin C and zinc, to support the nat-
ural process of recuperation [7].
The European black elderberries are rich dietary sources
of plant pigments and phenolic compounds. They contain
the flavonols, quercetin-3-glucoside and quercetin-3-ruti-
noside, and a number of anthocyanins: a group of phenolic
compounds responsible for the attractive red, purple, and
violet colours of many fruits, flowers, vegetables, and also
elderberries. The anthocyanins of elderberries were identi-
fied as cyanidin-3-sambubioside-5-glucoside, cyanidin-
3,5-diglucoside, cyanidin-3-sambubioside, cyanidin-3-glu-
coside, cyanidin-3-rutinoside, pelargonidin-3-glucoside,
and pelargonidin-3-sambubioside. The anthocyanins of
elderberries are bioactive; for example, able to enhance the
postprandial plasma antioxidant status of healthy humans
[10-13]. Animal and in vitro studies have shown that
anthocyanins decrease necrotic and apoptotic cell death
and lower infarct risks through anti-inflammatory and
relaxant effects on coronary arteries [14].
Influenza virus (IV) infections cause seasonal epi-
demics and have the potential to become pandemic.
Only a few medications are approved for use in the
treatment of influenza A and B virus infections while
they act directly and specifically against influenza
viruses, the problem with these medications is that
drug-resistance can develop relatively quickly [15,16].
Thus, there is an urgent need for new and more broadly
based anti-influenza medications that do not allow resis-
tance. Active substances with an unspecific inhibitory
action against IV propagation–regardless of the viral
subtype–would probably not lead to resistance, if such
IVs do not evade inhibition by changes in their viral
properties [17]. Moreover, bacterial super-infection dur-
ing an ongoing IV infection can lead to severe pneumo-
nia [18], and therefore substances with dual action
against both types of pathogens–bacteria and IV–would
be of further interest.
We have shown that a standardized elderberry liquid
extract displays antimicrobial effects against the Gram-
positive bacteria Streptococcus pyogenes and group C and
G Streptococci, and the Gram-negative bacterium Bran-
hamella catarrhalis, which often cause infections of the
upper respiratory tract. As it was already known that
elderberry extract can display activity against IV, we
investigated the ability of a specific standardized extract
of black elderberries to impair the propagation of human
pathogenic influenza A and B virus strains, A/Thailand/
KAN-1/2004 (KAN-1, H5N1) and B/Massachusetts/71
(Mass), in cell culture at non-toxic concentrations.
Methods
Rubini elderberry liquid extract
The extract used in the trials is a proprietary product
known as Rubini and was supplied by BerryPharma AG
(Solinger Strasse 7, D-42799 Leichlingen, Germany). This
particular elderberry extract was chosen for our studies
because it is standardized by HPLC and always produced
from the same “Haschberg” variety of S. nigra L., which
is grown under cultivation in the Steiermark region of
Austria. The elderberry-to-extract ratio of the product is
18:1. The extract is concentrated and standardized using
membrane filtration to achieve a minimum anthocyanin
concentration of 3.2%. The concentration of anthocya-
nins is achieved using a mechanical filtration procedure
in which semipermeable membranes separate substances
according to their different molecular sizes. The HPLC
assay is based on the IFU N° 71, 1998 method, measured
at pH 1, 510 nm using cyanidin chloride (Sigma Aldrich)
for the reference standard.
All references to elderberry liquid extract in this study
refer to the same proprietary, standardized extract.
Bacterial strains
Strains of S. pyogenes,g r o u pCa n dGStreptococci,a n d
B. catarrhalis were directly isolated from patient sam-
ples and cultivated on sheep blood agar plates (37°C, 5%
CO2) and refreshed twice-weekly. Patient isolates were
characterized using different reference antibiotics (see
Additional file 1, Table S1). For the experiments, bac-
t e r i aw e r eg r o w ni na na p p r o p r i a t eb r o t ho v e r n i g h ta t
37°C with shaking at 180 rpm (Unitron, Infors). Over-
night cultures were diluted 1:50 in 20 ml fresh BHI
(Brain Heart Infusion) broth using a 100-ml Erlenmeyer
flask and were incubated at the conditions noted above
until they reached an optical density of OD600 nm 1.0.
Cell line & viruses
Madin Darbin canine kidney cells (MDCK) were grown
in DMEM (1x DMEM supplemented with 10% FCS,
100 U/ml penicillin, 100 μg/ml streptomycin). The fol-
lowing influenza virus strains were used: The human
HPAIV isolate A/Thailand/KAN-1/2004 (KAN-1, H5N1)
was supplied to S. Pleschka by P. Puthavathana, Thai-
land. The human strain B/Massachusetts/71 (B/Mass)
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Germany. KAN-1 and B/Mass were propagated on
MDCK cells with low serum without trypsin for KAN-1
and with trypsin (2 μg/ml) for B/Mass. Strains were
titrated by focus assay (see below).
Testing of antimicrobial activity of elderberry liquid
extract in liquid cultures
The strains were grown at 37°C at 180 rpm for 12-16 h.
The optical density was measured at OD600 nm and dif-
ferences were adjusted by taking different volumes to
obtain the same amounts of bacteria.
Volumes of one milliliter fresh media were inoculated
with 50 μl of bacteria overnight-cultured in 1.5-ml
Eppendorf tubes. Elderberry liquid extract was added in
amounts of 5%, 10%, 15%, or 20%. The prepared tubes
were kept at 37°C and 180 rpm for another 16 h. Out of
the tubes, 100 μl were diluted, plated on blood agar
(Oxoid), and incubated at 37°C in broth for 24 h. Col-
ony forming units (CFU) were counted and the counts
were recalculated by factoring in the formerly made
dilutions. Plated bacteria without any elderberry extract
were set as 100% of possible growth. Growth figures
from isolates exposed to elderberry liquid extract were
set in relation to the strains not exposed to the extract.
Every biological experiment was independently repeated
at least three times with two replicates per trial.
MTT assay
MDCK cells grown in 96-well microplates were incu-
bated with DMEM/BA media (1x DMEM, 0.2% BA,
100 U ml
-1 penicillin and 0.1 mg ml
-1 streptomycin)
with different concentrations of elderberry extract (as
described under Materials and Methods, page 6) at
37°C, 5% CO2 for 12, 24, 36 and 48 h (16 wells per con-
centration and time point). The media was then aspi-
rated and the cells were left to recover for 60 min in
DMEM which was then replaced by 200 μl of MTT-mix
(DMEM supplemented with 10% FCS and antibiotics
containing 175 μg/ml MTT = 1-(4,5-dimethylthiazol-2-
yl)-3,5-diphenylformazan; Sigma). The cells were further
incubated for 90 min at 37°C and subsequently fixed
with 4% PFA (in PBS) for 30 min at RT. The cells were
dried and the tetrazolium crystals were dissolved by
adding 200 μl of isopropanol to each well. The plates
were shaken for 10 min and analyzed photometrically at
560 nm excitation in an enzyme-linked immunosorbent
assay (ELISA) reader.
Focus assay
MDCK cells grown in 96-well plates in DMEM to about
9 0 %c o n f l u e n c yw e r ew a s h e do n c ew i t hP B S + +a n d
infected with 50 μl virus of a dilution resulting in about
100 foci/well in PBS/BA, for 1 h RT. The inoculum was
aspirated and 150 μl MC-media (1x DMEM, 1.5%
Methyl cellulose; Methocel MC, Fluka) for KAN-1 and
Avicel-media (1x DMEM, 1.25% Avicel; FMC, Belgium)
for B/Mass were added and the cells were incubated at
37°C, 5% CO2, for 36 h and 48 h. To detect foci of
infected cells, the cells were fixed and permeabilized
using 100 μl fixing solution (4% PFA, 1% Triton X-100
in PBS++) at 4°C for 60 min. The solution was then dis-
carded and the cells were washed 3x with PBS++/0.05%
Tween20 and further incubated with 50 μl 1st antibody
(mouse-anti-Influenza A Nucleoprotein mAb, BIOZOL
BZL 10908) diluted in PBS++, 3% BSA, for 1 h at RT.
The cells were then were washed 3x with PBS++, 0.05%
Tween20 and incubated with 50 μlo f2 n da n t i b o d y
(anti-mouse HRP-antibody) diluted in PBS++, 3% BSA,
for 1 h at RT. The cells were then washed 3x with PBS+
+, 0.05% Tween20 and incubated in 40 μl/well “AEC”
staining solution (Sigma) for 45 min at RT. After suffi-
cient staining, the substrate was removed and the cells
were washed 2x with dH2O to remove salts. To detect
the size of foci (indicating a productive replication), the
96-well plates were scanned and analyzed using Photo-
shop software package.
Statistical data analysis of experiments
All experiments were performed a minimum of three
times. Significant differences between two values were
compared with a paired Student’st - t e s t .V a l u e sw e r e
considered significantly different when the p value was
less than 0.05 (p < 0.05).
Biosafety
All experiments using infectious virus were performed
in accordance with German regulations applicable to the
propagation of influenza viruses. All experiments invol-
ving highly pathogenic influenza A virus were performed
at a biosafety level 3 (BSL3) containment laboratory
approved for such use by the local authorities (RP, Gies-
sen, Germany).
Results
Antimicrobial activity of elderberry liquid extract in
bacterial liquid cultures
We used growth experiments in liquid cultures to
assess the antimicrobial activity of a standardized
elderberry liquid extract against Gram-positive bacteria
of S. pyogenesa n dg r o u pCa n dGStreptococci,a n dt h e
Gram-negative bacterium B. catarrhalis.C F U sw e r e
determined 16 hours after plating the bacteria on
blood agar at different concentrations of the elderberry
liquid extract (Figure 1). The addition of the elderberry
extract at a concentration of 10% to bacterial strains in
liquid culture media decreased their growth by >70%
in comparison to untreated samples. A concentration
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resulted in bacterial development under one percent of
t h eo r i g i n a l l ym e a s u r e dv a l u e s .
Antimicrobial activity of the elderberry liquid extract
against the bacterial organisms in liquid broth was evi-
dent from lower concentrations of the extract compared
to the results obtained with agar plates using disc diffu-
sion methods. Whereas growth-inhibitory effects were
f o u n df r o mt h ee x t r a c ta g a i n s tHaemophilus influenzae
using disc diffusion methods, it showed no inhibitory
effects against the growth of the Gram-positive bacteria,
Staphylococcus aureus (MRSA and MSSA) and Strepto-
coccus mutans, and the Gram-negative bacterium of
H. parainfluenzae (data not shown).
Inhibitory activity of elderberry liquid extract on the
propagation of B/Massachusetts/71 (B/Mass) and A/
Thailand/KAN-1/2004 (KAN-1, H5N1) in cell culture by
focus size reduction assay and titration of infectious
particles
We first determined the concentration at which the
extract could be tested for antiviral activity without
cytotoxic effects by the MTT assay. This comprises the
highest concentration of the extract that is still tolerable
in cell culture and was expected to show the strongest
activity and no, or barely any, cytotoxic activity. We
found that a 1:100 dilution of the extract in media met
both criteria.
MDCK cells were infected for 1 h with the IV strains
B/Massachusetts/71 (B/Mass) and A/Thailand/KAN-1/
2 0 0 4( K A N - 1 ,H 5 N 1 )a tad o s et h a ta l l o w se a s yf o c u s
detection. After removal of the inoculum, the cells were
incubated for 48 h with overlay media in the presence
of elderberry extract at the chosen concentration. The
supernatant was then disc a r d e da n dt h ef o c is i z ew a s
determined by focus assay.
At 48 h post-infection (p.i.), the elderberry extract
treatment produced a clear reduction of foci size for B/
Mass compared to the untreated control (Figure 2A). In
summary, the elderberry liquid extract treatment
reduces spread of the virus in cell culture. Interestingly,
the results also show that the foci size of KAN-1 is actu-
ally not reduced but enlarged compared to the untreated
control, whereas on the other side the result shows that
the number of foci is reduced compared to the
untreated control (Figure 2A). Furthermore, the total
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Figure 1 Effect of the elderberry extract on bacterial growth.
Visualization of Gram-positive and Gram-negative bacterial strains
exposed to different concentrations of Rubini elderberry extract
during growth in liquid culture. Every biological experiment was
independently repeated at least three times with two replicates per
trial. Standard deviation is indicated. The p < 0.05 was observed for
all bacterial species tested.
Figure 2 Impact of the elderberry extract on propagation of IV.
A) Focus size reduction assay. MDCK cells were infected with the
two virus strains as indicated and incubated for 48 h in the
presence of the extract (1:100). Foci were detected by
immunochemistry. B) Pre-treated MDCK cells were infected with
pre-treated virus and were propagated for 48 h in the presence of
the extract. As control untreated virus and cells were used for
infection. The mean titre of three independent experiments is given
as percentage of the control (black) set to 100%. Standard deviation
is indicated (KAN-1: p < 0.07, Mass: p < 0.03).
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infected with pre-treated virus and incubated in the pre-
sence of the extract (1:100) was determined. For the
respective virus strains, the results show that a reduction
of about 30% (KAN-1) and 25% (Mass) can be achieved
(Figure 2B).
Discussion
The goal of this study was to determine the potential
antimicrobial activity of a standardized elderberry liquid
extract against several human bacterial and viral patho-
gens known to cause infections of the upper respiratory
tract. We showed that the proliferation of S. pyogenes,
g r o u pCa n dGStreptococci,a n dB. catarrhalis were
reduced after contact with elderberry extract in liquid
culture. Our results indicate that the applied concentra-
tions of the elderberry liquid extract are an important
antimicrobial parameter for further potential therapeutic
treatment of bacterial pathogens.
The antimicrobial activity of an extract of elderberries
(S. nigra L.) has been demonstrated against the growth
of 13 common nosocomial Gram-positive and Gram-
negative pathogens (e.g. S. aureus (MRSA), Bacillus cer-
eus, Escherichia coli and Pseudomonas aeruginosa) using
t h ed i s cd i f f u s i o nt e c h n i q u e[ 1 9 ] .I n t r i g u i n g l y ,t h e
authors reported that all noscomial strains, including
S. aureus treated with an aqueous extract of the leaves
at 10-fold dilution, failed to show any growth inhibitory
activity, whereas 100-fold dilutions of freeze-dried, con-
centrates of ethanol extracts of the flowers or berries
inhibited all the bacteria tested [19]. In our data, S. aur-
eus (MRSA and MSSA) was not inhibited using Rubini
elderberry liquid extract using disc diffusion assays. This
strongly suggests that, compared to the elderberry
extract prepared by membrane filtration used in our
study, the extracts prepared by the method of Hearst
and colleagues [19] may be significantly different. We
speculate that the reasons for the different antimicrobial
activities of the two elderberry extracts could depend on
their chemical compositions or varying concentrations
of antibacterial compounds within the extracts. Both
studies demonstrate that elderberry extracts generated
by different extraction methods may be useful as alter-
native or complementary medicines to potentially coun-
teract the spread of certain kinds of bacteria responsible
for upper respiratory tract infections. Finally, additional
investigations are required to elucidate the mechanism
of action of elderberry extracts against bacteria.
Syncytia inhibition assays have shown that elderberry
extracts have strong antiviral activity against feline
immunodeficiency virus (FIV) in vitro [20]. Also, flavo-
noids in the berries of S. nigra L. bind to and prevent
H1N1-type IV infection in vitro [6]. Furthermore, influ-
enza A and B virus bind to alpha2,3- and alpha2,6-
linked sialic acid-linked glycoproteins as receptor deter-
minants for infection via the viral haemagglutinin (HA)
protein, and alpha2,6-linked sialic acid are recognized by
the S. nigra L. agglutinin [21]. We therefore aimed to
elucidate the anti-IV potential of the specific elderberry
extract used in our investigations against a B-type IV
(B/Mass) as well as a human isolate of a highly patho-
genic avian IV (KAN-1, H5N1).
We have demonstrated that treatment of IV-infected
cells with the elderberry liquid extract reduces B/Mass
spread at concentrations that are non-toxic in cell culture
and therefore should affect factors and/or mechanisms
important for influenza B virus propagation. Interestingly,
KAN-1 also showed a decrease in focus numbers, but at
the same time, an enlargement in size. At the moment,
this is not understood. Nevertheless, both virus strains
show reduced titres after pre-treated MDCK cells were
infected with the pre-treated strains, which were subse-
quently incubated in the presence of the extract for 48 h.
The difference in the effect of the extract on the propaga-
tion of the two strains may reflect different viral depen-
dencies on the factors or mechanisms blocked by the
extract and therefore the extract might have different inhi-
bitory potentials towards diverse types of IV. Looking at
the different treatment regimens, pre-treatment of the
cells had only a moderate effect in reducing KAN-1 titre
in a single cycle replication (data not shown). The result
would suggest that elderberry liquid extract blocks factors
on the cell surface needed by KAN-1 (and therefore per-
haps by other IV) for efficient infection of MDCK cells. It
should be noted that the experiments were otherwise per-
formed with pre-treated virus and cells and that the cells
were further incubated in the presence of the diluted
extract. Since preliminary results of other investigations
indicate an inhibitory effect of elderberry liquid extracts
against influenza A and B viruses [8,9], it can be concluded
that the molecular target of elderberry extract is common
to both viral genera. While this could be a specific as well
as a nonspecific target, previous studies have shown that
flavonoid components of the berries appear to exhibit a
specific neuraminidase-inhibiting effect [4] and bind to the
viral envelope of influenza [5]. Further work in elucidating
the specific activity of Rubini elderberry liquid extract will
allow a better understanding of its mode of action and
therefore of its potential applications.
Regarding the usability of the elderberry liquid extract
for in vivo testings, a compromise between concentration
and low viscosity should be found to provide the best
possible results. For practical purposes, an optimum
route of administration would need to be determined
and it would have to be decided which strategy to pursue
in considering the potential of the extract. Combining
the liquid extract with additional ingredients with the
goal of increasing its effects might also be considered,
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be used in combination with the extract for different
kinds of therapeutic applications [22].
Conclusion
Rubini elderberry liquid extract is active against human
pathogenic bacteria as well as influenza viruses, both
being clinically import groups of pathogens for which
new and alternative therapeutic approaches are needed.
In addition, bacterial super-infection during ongoing
influenza virus infections complicates the situation for
the patient. It would therefore be useful to simulta-
neously target both foes. The activities shown by the
elderberry liquid extract suggest that additional and
alternative approaches to influenza infections might be
provided by natural products.
Additional material
Additional file 1: Antibiotic susceptibilities of the employed
bacterial strains against penicillin G, doxycycline, clindamycin,
cefazolin, cefuroxime and ceftazidime. Table S1.
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